Jinxin Reproductive (01951) rose 3.3 percent in early tradingnftgamescrypto.88%nftgamescrypto, currently quoted at HK$3.48, with a turnover of HK$92.8824 million.
Recently, the Shanghai City Medical Insurance Bureau, together with the Human Resources and Social Security and the Health Department, issued the "Notice on Including Some Therapeutic Assisted Reproductive Technology Projects into the Coverage of Medical Insurance and Work Injury Insurance." Starting from June 1 this year, 12 assisted reproductive medical services will be included in the scope of medical insurance payment, covering necessary medical assisted reproductive technologies such as oocyte retrieval, sperm retrieval, artificial insemination, embryo culture, and embryo transfer. It is reported that since the beginning of this year, five provinces including Inner Mongolia, Gansu, Xinjiang, Shandong and Jiangxi have included assisted reproduction in medical insurance.
Southwest Securities pointed out that the assisted reproduction market has vast space and policies help increase industry penetration. According to the Sullivan report, the size of my country's assisted reproduction market in 2020 will be 43.4 billion yuan, and it is expected that the size of my country's assisted reproduction market will reach 85.4 billion yuan by 2025. Investment recommendation: Vertical comparison of medical service segments shows that assisted reproduction has high barriers and high profit margins. It is recommended to pay attention to assisted reproduction medical service institutions, including Jinxin Reproduction.